HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

N- (2- aminophenyl)- 4- ((4- pyridin- 3- ylpyrimidin- 2- ylamino)methyl)benzamide

undergoing phase II clinical trials for treatment of cancer
Also Known As:
MG 0103; MG 4230; MG 4915; MG 5026; MG-0103; MG-4230; MG-4915; MG-5026; MG0103; MG4230; MG4915; MG5206; MGCD 0103; MGCD-0103; MGCD0103
Networked: 29 relevant articles (2 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Li, Zuomei: 5 articles (11/2010 - 04/2008)
2. Garcia-Manero, Guillermo: 4 articles (06/2011 - 08/2008)
3. Martell, Robert E: 4 articles (11/2010 - 04/2008)
4. Besterman, Jeffrey M: 4 articles (08/2008 - 04/2008)
5. Zhang, Qingwei: 3 articles (01/2015 - 09/2014)
6. Yang, Hui: 3 articles (10/2010 - 08/2008)
7. Bonfils, Claire: 3 articles (08/2008 - 04/2008)
8. Kalita, Ann: 3 articles (08/2008 - 04/2008)
9. Siu, Lillian L: 3 articles (08/2008 - 04/2008)
10. Hu, Lufeng: 2 articles (01/2015 - 01/2015)

Related Diseases

1. Hodgkin Disease (Hodgkin's Disease)
2. Pain (Aches)
3. Neoplasms (Cancer)
4. Lymphoma (Lymphomas)
5. Leukemia

Related Drugs and Biologics

1. Histone Deacetylase Inhibitors
2. N- (2- aminophenyl)- 4- (N- (pyridin- 3- ylmethoxycarbonyl)aminomethyl)benzamide (MS 275)
3. Bee Venoms (Bee Venom)
4. Immunotoxins (Immunotoxin)
5. cAC10-vcMMAE
6. Valproic Acid (Valproate, Semisodium)
7. vorinostat (suberoylanilide hydroxamic acid)
8. Sodium
9. romidepsin (FK228)
10. Histone Deacetylases (Histone Deacetylase)

Related Therapies and Procedures

1. Stents
2. Heterologous Transplantation (Xenotransplantation)